Published in Surgery Litigation and Law Weekly, January 19th, 2007
Study 1: Scientists discuss in "Rapid detection of rifampicin-resistant Mycobacterium tuberculosis by in-house, reverse line blot assay" new findings in tuberculosis. According to recent research from New Delhi, India, "Drug resistance in tuberculosis is a significant problem in countries endemic for tuberculosis. A sensitive, specific, and high-throughput reverse line blot assay (RLBA) for the detection of genotypic resistance to rifampicin (RIF) was designed and evaluated."
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Surgery Litigation and Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.